| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |